Sign in
CompletedNo phase

Assessment of Biomarkers in Children to Help Parents Quit Tobacco

Key facts

Who runs it
Massachusetts General Hospital
Where
Cleveland, United StatesSee the site
Trial code
Status
Completed
People taking part
865 people enrolled
Started
20 Jan 2023
Ended
1 May 2026
Type of study
Interventional, 2 groupsOne group gets an existing treatment, for comparison.
Treatments tested
  • CEASE
  • CEASE + BIO
Record updated
15 June 2026

Who can take part

Age
18 years and older
Sex
Women and men
Healthy volunteers
Can take part

The registry criteria, word for word

Show all 6 criteriaShow less

Who can take part

  • Child 12 years old or younger presenting for a visit
  • Child scheduled for or has had a clinically indicated blood draw at that visit
  • Parent/legal guardian of the child
  • Parent/legal guardian is a current smoker (past 7 days)

Who cannot take part

  • Parent/legal guardian is less than 18 years of age
  • Parent/legal guardian is non-English speaking

Where in United States

  • MetroHealth SystemCleveland, United States

About the trial

What the trial wants to find out

This randomized controlled trial will test whether adding biomarker measurement and informed outreach for tobacco smoke exposure as part of routine practice increases identification and improves treatment, effectiveness, and sustainability of a parental tobacco control intervention that will be integrated into pediatric practice.

The 2 groups in the trial

  • CEASEExisting treatment, for comparison

    Those assigned to the Active Comparator arm will receive the CEASE intervention.

  • CEASE + BIOTreatment being tested

    Those assigned to the Experimental CEASE + BIO arm will receive the CEASE intervention plus Biomarker Informed Outreach (BIO).

    Treatment: CEASE and CEASE + BIO

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Record updated
15 June 2026